Aselage Steve Insider Trades

Insider Trading History

Track insider trading activity for Aselage Steve. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Director
Holding Value $579k 70,159 shares
Last Trade
Jun 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$315k 49,933 shares
$6.30
$8.25
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Director
Holding Value $20.6k 2,500 shares
Last Trade
May 24, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$16k 2,500 shares
$6.40
$8.25
Acer Therapeutics
Acer Therapeutics ACER
Director
Holding Value $0 0 shares
Last Trade
Nov 17, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$435k 483,741 shares
$0.90
$0.66
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Director
Holding Value $523k 63,339 shares
Last Trade
Jun 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$320k 39,072 shares
$8.18
$8.25
Acer Therapeutics
Acer Therapeutics ACER
Director
Holding Value $13.2k 20,000 shares
Last Trade
Mar 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$33.4k 20,000 shares
$1.67
$0.66
Acer Therapeutics
Acer Therapeutics ACER
Director
Holding Value $319k 483,741 shares
Last Trade
Nov 29, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$500k 409,836 shares
$1.22
$0.66
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Director
Holding Value $384k 46,594 shares
Last Trade
Jun 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$139k 12,866 shares
$10.79
$8.25
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Director
Holding Value $248k 30,022 shares
Last Trade
Jun 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$324k 30,022 shares
$10.79
$8.25
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Director
Holding Value $278k 33,728 shares
Last Trade
May 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.3k 569 shares
$9.31
$8.25
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $6.64M 146,919 shares
Last Trade
May 11, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$56.4k 2,575 shares
$21.92
$45.20
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Director
Holding Value $274k 33,159 shares
Last Trade
Feb 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5k 301 shares
$16.61
$8.25
Acer Therapeutics
Acer Therapeutics ACER
Director
Holding Value $12.2k 18,500 shares
Last Trade
Jan 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$40.9k 18,500 shares
$2.21
$0.66
Acer Therapeutics
Acer Therapeutics ACER
Director
Holding Value $48.8k 73,905 shares
Last Trade
Dec 10, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$16.3k 7,984 shares
$2.04
$0.66
Acer Therapeutics
Acer Therapeutics ACER
Director
Holding Value $43.5k 65,921 shares
Last Trade
Dec 09, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.33k 2,016 shares
$2.15
$0.66
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Director
Holding Value $271k 32,858 shares
Last Trade
Nov 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.99k 414 shares
$12.06
$8.25
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $6.76M 149,494 shares
Last Trade
Nov 16, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$935k 31,800 shares
$29.39
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $7.77M 171,794 shares
Last Trade
Nov 05, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$301k 10,000 shares
$30.10
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $7.31M 161,794 shares
Last Trade
Nov 05, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$301k 10,000 shares
$30.10
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $3.16M 70,000 shares
Last Trade
Nov 05, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$301k 10,000 shares
$30.10
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $881k 19,500 shares
Last Trade
Nov 02, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$105k 3,500 shares
$30.00
$45.20

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up